Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Revenue (2016 - 2025)

Lisata Therapeutics (LSTA) has disclosed Revenue for 10 consecutive years, with $1.0 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Revenue changed N/A year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $1.0 million, changed N/A over the prior year.
  • Revenue was $1.0 million for Q4 2024 at Lisata Therapeutics, up from -$1666.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.0 million in Q4 2024 and bottomed at $1.0 million in Q4 2024.